Blog
RSS FeedPosted by Michael Wonder on 11 Jul 2025
Zepbound KwikPen (tirzepatide), the first and only dual receptor agonist for the treatment of obesity, now approved and available in Canada
9 July 2025 - Eli Lilly Canada is pleased to announce that Zepbound KwikPen (tirzepatide injection) is now available in Canada, ...
Posted by Michael Wonder on 10 Jul 2025
Albanese should consider tweaks to PBS to avoid Trump tariff: CSL chair
9 July 2025 - Donald Trump’s move to ramp up tariffs on medicines and copper has sparked alarm among government ...
Posted by Michael Wonder on 09 Jul 2025
PBS ‘not on the table’ in battle for pharmaceutical tariff exemption, despite lobbying
9 July 2025 - The threat of global 200 per cent tariffs on pharmaceutical products presents a challenge to Australia’s drug ...
Posted by Michael Wonder on 07 Jul 2025
Will miracle HIV drug go on the PBS?
5 July 2025 - A new twice yearly antiviral injection that can prevent HIV is likely to be approved soon in ...
Posted by Michael Wonder on 03 Jul 2025
Bayer's Adempas gets insurance coverage in Korea 11 years after approval
21 May 2025 - The pulmonary arterial hypertension medicine Adempas (riociguat) will be covered by national health insurance starting next ...
Posted by Michael Wonder on 03 Jul 2025
Top level push for taxpayer funding of weight loss drugs gathers pace
3 July 2025 - Pharma giants are sweating on the results of a federal government request for guidance on adding weight ...
Posted by Michael Wonder on 02 Jul 2025
Calls for 'missing piece' menopause drug to be added to the PBS
2 July 2025 - A key treatment which could help around one million middle-aged Australian women remains unaffordable to many ...
Posted by Michael Wonder on 02 Jul 2025
Life-saving breast cancer drug now cheaper thanks to expansion of the PBS
1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...
Posted by Michael Wonder on 01 Jul 2025
New Zealand Pharmaceutical Schedule - 1 July 2025
1 July 2025 - The July 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Jul 2025
Schedule of Pharmaceutical Benefits - 1 July 2025
1 July 2025 - The July 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 24 Jun 2025
Australians with cystic fibrosis benefit from life changing expanded listing
24 June 2025 - More Australians living with cystic fibrosis will have affordable access to a life changing treatment option ...
Posted by Michael Wonder on 23 Jun 2025
‘Barriers lifted’: cystic fibrosis treatment reaches final waiting patients
23 June 2025 - Ex-Wallabies player Nathan Charles has lived with cystic fibrosis for decades. ...
Posted by Michael Wonder on 22 Jun 2025
‘The sky’s the limit’: how Australian scientists rewrote the cancer script
20 June 2025 - A major shift in cancer treatment will be publicly funded and is set to dramatically increase the ...
Posted by Michael Wonder on 18 Jun 2025
PHARMAC funding U turn for patients
16 June 2025 - Associate Health Minister David Seymour says the oestradiol patch funding decision is an example of PHARMAC’s ...
Posted by Michael Wonder on 18 Jun 2025
PHARMAC to fund two brands of oestradiol patches from 1 December 2025
16 June 2025 - PHARMAC will fund two brands of oestradiol patches – Estradot and Estradiol TDP Mylan – from ...